These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 8420206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
    Manson AJ, Turner K, Lees AJ.
    Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.
    Nyholm D, Constantinescu R, Holmberg B, Dizdar N, Askmark H.
    Acta Neurol Scand; 2009 May; 119(5):345-8. PubMed ID: 18822087
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Apomorphine and lisuride infusion. A comparative chronic study.
    Stocchi F, Bramante L, Monge A, Viselli F, Baronti F, Stefano E, Ruggieri S.
    Adv Neurol; 1993 May; 60():653-5. PubMed ID: 8420205
    [No Abstract] [Full Text] [Related]

  • 9. Apomorphine test in de novo Parkinson's disease.
    Bonuccelli U, Piccini P, Del Dotto P, Pavese N, D'Antonio P, Muratorio A.
    Funct Neurol; 1992 May; 7(4):295-8. PubMed ID: 1427361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
    Sage JI, Sonsalla PK, McHale DM, Heikkila RE, Duvoisin RC.
    Adv Neurol; 1990 May; 53():383-6. PubMed ID: 2122646
    [No Abstract] [Full Text] [Related]

  • 12. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease.
    Syed N, Murphy J, Zimmerman T, Mark MH, Sage JI.
    Mov Disord; 1998 Mar; 13(2):336-8. PubMed ID: 9539350
    [Abstract] [Full Text] [Related]

  • 13. Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
    Deutschländer A, Asmus F, Marelli E, Klopstock T, Gasser T, Bötzel K.
    Mov Disord; 2006 Sep; 21(9):1523-5. PubMed ID: 16755578
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.
    Stocchi F, Vacca L, De Pandis MF, Barbato L, Valente M, Ruggieri S.
    Neurol Sci; 2001 Feb; 22(1):93-4. PubMed ID: 11487217
    [Abstract] [Full Text] [Related]

  • 16. [Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease].
    Pollak P, Champay AS, Gaio JM, Hommel M, Benabid AL, Perret J.
    Rev Neurol (Paris); 1990 Feb; 146(2):116-22. PubMed ID: 2320817
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.
    Larsen JP, Boas J.
    Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975
    [Abstract] [Full Text] [Related]

  • 20. The beneficial effect of chronic lisuride administration compared with levodopa in Parkinson's disease.
    Rabey JM, Streifler M, Treves T, Korczyn AD.
    Adv Neurol; 1990 Mar; 53():451-5. PubMed ID: 2122652
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.